ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1593

Perceived Impact of the COVID-19 Pandemic on Physical Activity Among Adult Patients with Rheumatologic Disease

Teresa Dickson1, Tessa Englund1, Emily McCormick1, Becki Cleveland1, Kelli Allen2, Andres Santana1, Shruti SaxenaBeem1, Julie Walker1 and Saira Sheikh3, 1Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 2Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC and Health Services Research & Development, Durham VA Health Care System, Durham, NC, 3University of North Carolina Thurston Arthritis Research Center, and Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC

Meeting: ACR Convergence 2021

Keywords: COVID-19, Patient reported outcomes, physical activity, socioeconomic factors, Surveys

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster IV: COVID-19 (1589–1613)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: The COVID-19 pandemic has triggered nationwide disruptions that limit opportunities for physical activity (PA). Addressing suboptimal levels of PA is important for disease management and reducing risk of comorbidities in patients with rheumatologic conditions. The objective of this cross-sectional study was to investigate the impact of the COVID-19 pandemic on PA levels of patients with rheumatologic disease and to examine characteristics associated with decreased PA that may inform future PA interventions.

Methods: A convenience sample of adult patients with rheumatologic disease (n=7,776) were identified through electronic medical records from an academic healthcare system in North Carolina. Eligible patients were invited to participate in an online survey between July–September 2020. Rheumatologic and concurrent diagnoses as well as patient-reported outcomes during the COVID-19 pandemic were assessed, which included changes in PA, barriers to PA, psychological symptoms, and wellbeing. Descriptive statistics, age-adjusted odds ratios (OR), and 95% confidence intervals (CI) were computed to compare characteristics of those whose activity decreased versus those who did not (stayed the same or increased).

Results: A total of 1,133 participants completed the survey (17.2% response rate, mean age of sample: 57.6 ± 15.2 years, 75.4% female, 82.3% white and 14.1% African American). The most common primary diagnoses reported among participants include RA (25.6%), OA (14.6%), and SLE (12.6%). Over half of participants (55.5%) reported engaging in less PA since the start of the pandemic, followed by unchanged PA (26.6%) and increased PA (15.3%). Factors associated with engaging in less PA were male sex (OR 0.75, CI 0.57-0.99), lower income during the COVID-19 pandemic (OR 1.34, CI 1.01-1.79), and lower self-reported fair/poor health (OR 2.50, CI 1.91-3.27). Among rheumatologic diseases, a diagnosis of SLE was associated with lower self-reported PA (OR 1.59, CI 1.07-2.37). Comorbidities associated with decreased PA include chronic pain (OR 1.38, CI 1.04-1.82), depression (OR 1.48, CI 1.09-2.01), and hypertension (OR 1.44, CI 1.10-1.90). The most common reported barriers to PA include increased overall fear/anxiety (33.5%), lack of motivation (32.4%), and contracting coronavirus infection (32.1%). Most participants reported that they did not meet their exercise goals during the COVID-19 pandemic (67.2%).

Conclusion: The COVID-19 pandemic has further exacerbated barriers to PA in patients with rheumatologic diseases. There is a critical need to provide resources, support and multi-faceted to encourage PA in patients with rheumatologic diseases during the COVID-19 pandemic and beyond.


Disclosures: T. Dickson, None; T. Englund, None; E. McCormick, None; B. Cleveland, None; K. Allen, None; A. Santana, None; S. SaxenaBeem, None; J. Walker, None; S. Sheikh, Pfizer, 5, GlaxoSmithKline, 2, 5.

To cite this abstract in AMA style:

Dickson T, Englund T, McCormick E, Cleveland B, Allen K, Santana A, SaxenaBeem S, Walker J, Sheikh S. Perceived Impact of the COVID-19 Pandemic on Physical Activity Among Adult Patients with Rheumatologic Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/perceived-impact-of-the-covid-19-pandemic-on-physical-activity-among-adult-patients-with-rheumatologic-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceived-impact-of-the-covid-19-pandemic-on-physical-activity-among-adult-patients-with-rheumatologic-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology